|ZFIN ID: ZDB-PUB-131010-4|
|Source:||Drug Discovery Today: Technologies 10(1): e109-e114 (Review)|
|Registered Authors:||Chico, Tim J.|
|PubMed:||24050238 Full text @ Drug Discov. Today Technol.|
The zebrafish is increasingly being adopted as an in vivo model of high throughput drug screening. In this brief review we outline the advantages and disadvantages of this approach and summarize recent screens that have attempted to identify novel small molecules with activity on the cardiovascular system.